These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29719256)

  • 1. STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection.
    Van Dis E; Sogi KM; Rae CS; Sivick KE; Surh NH; Leong ML; Kanne DB; Metchette K; Leong JJ; Bruml JR; Chen V; Heydari K; Cadieux N; Evans T; McWhirter SM; Dubensky TW; Portnoy DA; Stanley SA
    Cell Rep; 2018 May; 23(5):1435-1447. PubMed ID: 29719256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against
    Jong RM; Van Dis E; Berry SB; Nguyenla X; Baltodano A; Pastenkos G; Xu C; Fox D; Yosef N; McWhirter SM; Stanley SA
    J Immunol; 2022 Jan; 208(2):407-419. PubMed ID: 34965963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
    Fukui M; Shinjo K; Umemura M; Shigeno S; Harakuni T; Arakawa T; Matsuzaki G
    Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
    Orr MT; Beebe EA; Hudson TE; Argilla D; Huang PW; Reese VA; Fox CB; Reed SG; Coler RN
    Vaccine; 2015 Nov; 33(48):6570-8. PubMed ID: 26541135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.
    Pitt JM; Stavropoulos E; Redford PS; Beebe AM; Bancroft GJ; Young DB; O'Garra A
    J Immunol; 2012 Oct; 189(8):4079-87. PubMed ID: 22972927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BALB/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL/6 mice but have equivalent protection.
    Garcia-Pelayo MC; Bachy VS; Kaveh DA; Hogarth PJ
    Tuberculosis (Edinb); 2015 Jan; 95(1):48-53. PubMed ID: 25467292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationalized design of a mucosal vaccine protects against
    Ahmed M; Jiao H; Domingo-Gonzalez R; Das S; Griffiths KL; Rangel-Moreno J; Nagarajan UM; Khader SA
    J Leukoc Biol; 2017 Jun; 101(6):1373-1381. PubMed ID: 28258153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
    Poyntz HC; Stylianou E; Griffiths KL; Marsay L; Checkley AM; McShane H
    Tuberculosis (Edinb); 2014 May; 94(3):226-37. PubMed ID: 24572168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells.
    Ahmad S; Bhattacharya D; Gupta N; Rawat V; Tousif S; Van Kaer L; Das G
    PLoS Pathog; 2020 May; 16(5):e1008356. PubMed ID: 32437421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants.
    Franco AR; Peri F
    Cells; 2021 Jan; 10(1):. PubMed ID: 33466444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection.
    Wang C; Lu J; Du W; Wang G; Li X; Shen X; Su C; Yang L; Chen B; Wang J; Xu M
    Vaccine; 2019 Jul; 37(32):4477-4484. PubMed ID: 31266673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus Calmette-Guérin Overexpressing an Endogenous Stimulator of Interferon Genes Agonist Provides Enhanced Protection Against Pulmonary Tuberculosis.
    Dey RJ; Dey B; Singh AK; Praharaj M; Bishai W
    J Infect Dis; 2020 Mar; 221(7):1048-1056. PubMed ID: 30901058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
    Ashhurst AS; Parumasivam T; Chan JGY; Lin LCW; Flórido M; West NP; Chan HK; Britton WJ
    PLoS One; 2018; 13(3):e0194620. PubMed ID: 29554138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.
    Rai PK; Chodisetti SB; Zeng W; Nadeem S; Maurya SK; Pahari S; Janmeja AK; Jackson DC; Agrewala JN
    J Transl Med; 2017 Oct; 15(1):201. PubMed ID: 28985739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses.
    Luo W; Qu Z; Zhang L; Xie Y; Luo F; Tan Y; Pan Q; Zhang XL
    Vaccine; 2018 May; 36(21):2998-3009. PubMed ID: 29681409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection.
    Dijkman K; Aguilo N; Boot C; Hofman SO; Sombroek CC; Vervenne RAW; Kocken CHM; Marinova D; Thole J; Rodríguez E; Vierboom MPM; Haanstra KG; Puentes E; Martin C; Verreck FAW
    Cell Rep Med; 2021 Jan; 2(1):100187. PubMed ID: 33521701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
    Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
    Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.